$BCCG Balance Sheet | Understand Stock

$BCCG

Financial Statements

In millions of USD, except per-share amounts

	Q1 FY2027 As of Aug 31, 2026	Q4 FY2026 As of May 31, 2026	Q3 FY2026 As of Feb 28, 2026	Q2 FY2026 As of Nov 30, 2025	Q1 FY2026 As of Aug 31, 2025	Q4 FY2025 As of May 31, 2025	Q3 FY2025 As of Feb 28, 2025	Q2 FY2025 As of Nov 30, 2024	Q1 FY2025 As of Aug 31, 2024	Q4 FY2024 As of May 31, 2024	Q3 FY2024 As of Feb 29, 2024	Q2 FY2024 As of Nov 30, 2023
ASSETS
Current Assets
Cash
Restricted cash
Total Current Assets
Other Assets
Software application
Total Other Assets
Total Assets
LIABILITIES AND STOCKHOLDERS’ (DEFICIT)
Current Liabilities
Overdraft
Accounts Payable
Nonrelated Party
Related Party
Total accounts Payable
Accrued officer Compensation
Accrued interest payable
Due to related parties
Related Party
Total due to related parties
Convertible notes payable, net of discount of $463,644 and $0, respectively
Notes Payable
Convertible notes payable, net of discount of $204,758 and $167,514 respectively
Convertible notes payable, net of discount of $12,735 and 243,767 respectively
Total Liabilities
Stockholders’ (Deficit)
Preferred Stock A, $0.0001 par value; 1,000,000 shares authorized, 999,999 issued and outstanding on August 31, 2026, and on May 31, 2026, respectively
Common stock, $0.0001 par value; 400,000,000 shares authorized, 109,093,228 issued and outstanding, on August 31, 2026, and 104,726,400 issued and outstanding on May 31, 2026
Additional paid-in capital
Accumulated deficit
Total Stockholders’ (Deficit)
Total Liabilities and Stockholders’ (Deficit)

Comments